Consumo de antidepresivos en un Servicio de Farmacia Hospitalaria en Santa Cruz de Tenerife

  1. Mariana Sapino Bitetti
  2. Sandra Dévora Gutiérrez 1
  3. Domingo Martín Herrera 1
  4. Juan Manuel Sánchez Sánchez
  5. Sheila Otazo Pérez
  6. Susana Abdala Kuri
  1. 1 Universidad de La Laguna. 2 Departamento de Medicina Física y Farmacología, Sección de Farmacia,
Majorensis: Revista Electrónica de Ciencia y Tecnología

ISSN: 1697-5529

Year of publication: 2018

Issue: 14

Pages: 12-18

Type: Article

More publications in: Majorensis: Revista Electrónica de Ciencia y Tecnología


Background and objectives: Depression is a disabling disease, actually it affects more than 300 million of people around the world, being the risk 2-3 higher in women than men. Taking into account the high incidence of depression and the increasing consumption of antidepressants in recent years, this project aims to quantify and analyze the consumption of this therapeutic group in a Hospital Pharmacy Service, located in Santa Cruz de Tenerife. Materials and methods: Antidepressant drug´s dispensations of the classification ATC “N06A. Antidepressants” group were assessed for one year, between January and December 2016, in the Hospital Pharmacy Service. Data obtained were classified by their therapeutic group and active ingredient. The data were obtained from pharmaceutical management software Financials and they were analyzed using the Microsoft Office Excel 2007 program. Results and discussion: In 2016 in the Hospital Pharmacy Service, 18,874 units in unitary dose were dispensed and the most commonly group used, which included trazadone and mirtazapine, was the named “atypical” antidepressant (50,66%). This group is the most adequate for elderly patients, commonly users of the hospital under study. SSRIs drugs, headed by sertraline, were the second most commonly group prescribed. Conclusions: The high consumption of the antidepressant drugs and its effectiveness depend mostly on an adequate and long term treatment adherence. For this reason, the hospital pharmacist interventions are necessary in order to guarantee the right compliance and reduce the treatment withdrawal rate.